Regulation of cellular trafficking and pathogenesis by mucins
粘蛋白对细胞运输和发病机制的调节
基本信息
- 批准号:07407063
- 负责人:
- 金额:$ 25.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aims of this proposal was to elucidate the biological roles of mucins in a variety of pathogenic processes focusing on their involvement in cellular recognition and trafficking. Epithelial mucins were investigated for their distribution, their biosynthetic regulation, and the mechanism of recognition by carbohydrate binding molecules (lectins). The importance of such recognition processes in cancer invasion and metastasis, allergic dermatitis, and other diseases was investigated. Important findings are listed herein : (1) A unique carbohydrate epitope in human colonic sulfomucin was identified as sulfo-LeィイD1aィエD1(HSOィイD23ィエD2-Galβ1-3[Fucα1-4]GlcNAc-). Mucins with this epitope, presumably MUC5B was found associated with gallstone in humans. Positional localization of mucins with this epitope was very similar between humans and mice as far as in the intestinal tracts. (2) The initial step of glycosylation of MUC2 mucin was investigated focusing on the maximum number and the order of … More GalNAc incorporation into multiple threonine residues. When a microsomal fraction of LS174T human colon carcinoma cells was used as a source of the enzyme, GalNAc incorporation was 100% to consecutive threonine residues whereas 〜50% to alternating threonine residues. Three recombinant UDP-GalNAc : peptide/N-acetylgalactosaminyltransferases (ppGalNAc-T1, T2, and T3) were tested for their capacity to transfer GalNAc into three consecutive threonine residues, the order and the maximum number was unique to each enzyme. (3) Recombinant human macrophage galactose/N-acetylgalactosamine-specific calcium-type lectin (hMGL) was tested for its interaction with MUC2 mucin peptides with various arrangement of attached GalNAc residues. hMGL, forming a trimeric configuration, was shown to preferentially bind MUC2 peptides with GalNAc on consecutive threonines. (4) A mucin-like high-molecular-weight and heavily glycosylated molecule was identified to be associated with mouse ovarian tumor OV2944 HM-1 cells. This molecule was recognized by a mouse macrophage C-type lectin (mMGL). OV2944 HM-1 variant cells selected for low mMGL binding, deficient in this cell surface mucin, were more metastatic to lymph nodes when injected subcutaneously into syngeneic mice. (5) Migration of mMGL positive dermal macrophages from the skin to lymph nodes were observed during the sensitization phase of contact dermatitis. Although mucins were already identified as one of natural ligands of mMGL, whether such a molecule in lymph nodes is involved in macrophage trafficking remains to be elucidated. Less
该提案的目的是阐明粘蛋白在各种致病过程中的生物学作用,重点是它们参与细胞识别和运输。研究了上皮粘蛋白的分布、生物合成调节以及糖结合分子(凝集素)的识别机制。研究了这种识别过程在癌症侵袭和转移、过敏性皮炎和其他疾病中的重要性。(1)在人结肠硫粘蛋白中发现了一个独特的糖表位,命名为硫代亮氨酸D1 α-GlcNAc D1(HSO亮氨酸D23-GlcNAc D2-Galβ1-3[Fucα1-4]GlcNAc-)。具有该表位的粘蛋白,推测为MUC 5 B,被发现与人类胆结石相关。粘蛋白与此表位的位置定位是非常相似的人类和小鼠之间的肠道。(2)研究了MUC 2粘蛋白糖基化的初始步骤,重点是MUC 2粘蛋白糖基化的最大数目和顺序。 ...更多信息 GalNAc掺入多个苏氨酸残基。当LS 174 T人结肠癌细胞的微粒体部分被用作酶的来源时,GalNAc掺入100%到连续的苏氨酸残基,而100%到交替的苏氨酸残基。三种重组UDP-GalNAc:测试肽/N-乙酰半乳糖胺转移酶(ppGalNAc-T1、T2和T3)将GalNAc转移到三个连续的苏氨酸残基中的能力,顺序和最大数目对于每种酶是独特的。(3)测试了重组人巨噬细胞半乳糖/N-乙酰半乳糖胺特异性钙型凝集素(hMGL)与具有各种连接的GalNAc残基排列的MUC 2粘蛋白肽的相互作用。形成三聚体构型的hMGL显示优先结合MUC 2肽与连续苏氨酸上的GalNAc。(4)一种粘蛋白样高分子量和高度糖基化的分子被鉴定为与小鼠卵巢肿瘤OV 2944 HM-1细胞相关。该分子被小鼠巨噬细胞C型凝集素(mMGL)识别。选择低mMGL结合的OV 2944 HM-1变体细胞(缺乏该细胞表面粘蛋白),当皮下注射到同基因小鼠中时,对淋巴结的转移性更大。(5)在接触性皮炎的致敏阶段,观察到mMGL阳性真皮巨噬细胞从皮肤迁移至淋巴结。虽然粘蛋白已被鉴定为mMGL的天然配体之一,但淋巴结中的这种分子是否参与巨噬细胞的运输仍有待阐明。少
项目成果
期刊论文数量(62)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Akatsu, T: "Chinese hamster ovary cells expressing〜." J.Bone Miner Res. 13. 1251-1259 (1998)
Akatsu, T:“中国仓鼠卵巢细胞表达〜。” J.Bone Miner Res. 13. 1251-1259 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawada, M.: "Up-regclation of p27 kipl correlates inversely〜." Jpn.Cancer Res.89. 110-115 (1998)
Kawada, M.:“p27 kipl 的上调呈反相关〜”。Jpn.Cancer Res.89 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakamori,S.: "In volvement of carbohydrate antigen sialyl Lewis-X in colorectal cancer metastasis." Dis.Colon.Rectum.40. 420-431 (1997)
Nakamori,S.:“碳水化合物抗原唾液酸路易斯-X 参与结直肠癌转移。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yonezawa, S.: "MUC-1 mucin expression in invasive areas〜." Pathology Int.48. 319-322 (1998)
Yonezawa, S.:“侵袭区域中的 MUC-1 粘蛋白表达。”病理学 Int.48(1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizuochi,S.: "Immunohistochemical study on a macrophage calcium-type lecttn〜"Glycoconjugate J. 15. 397-404 (1998)
Mizuochi, S.:“巨噬细胞钙型凝集素的免疫组织化学研究~” Glycoconjugate J. 15. 397-404 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRIMURA Tatsuro其他文献
IRIMURA Tatsuro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRIMURA Tatsuro', 18)}}的其他基金
Development of cancer stem cells driven by microenvironment
微环境驱动的癌症干细胞的发育
- 批准号:
26670023 - 财政年份:2014
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
MUC21 glycoforms as the target of cancer diagnosis and therapy
MUC21糖型作为癌症诊断和治疗的靶点
- 批准号:
25293011 - 财政年份:2013
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of IgA responses against influenza virus
流感病毒 IgA 反应的调节
- 批准号:
24659029 - 财政年份:2012
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
A peptide sequence motif which regulates glycoforms
调节糖型的肽序列基序
- 批准号:
22659016 - 财政年份:2010
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Immune-suppressive function of cancer-associated mucin epiglycanin/Muc21
癌症相关粘蛋白表聚糖蛋白/Muc21的免疫抑制功能
- 批准号:
21390018 - 财政年份:2009
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structural diversity of mucins : Significance in infection and immunity
粘蛋白的结构多样性:在感染和免疫中的意义
- 批准号:
12307054 - 财政年份:2000
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Establishment of hepatic metastasis model of pancreatic carcinoma and it application to the development of therapeutic agents
胰腺癌肝转移模型的建立及其在治疗药物开发中的应用
- 批准号:
11557180 - 财政年份:1999
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of Detection Systems and Expression Systems for Organ-Specific Mucins
器官特异性粘蛋白检测系统和表达系统的建立
- 批准号:
05557104 - 财政年份:1993
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Cell surface glycoconjugates and adhesion molecules
细胞表面糖复合物和粘附分子
- 批准号:
04454591 - 财政年份:1992
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
CAN/lectin 7信号通路调控棉铃虫对Cry1Ac蛋白的免疫机制解析
- 批准号:32172401
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
血栓调节蛋白lectin区优势突变引起血栓形成的分子机制及其干预措施
- 批准号:81973995
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
靶向Lectin受体多功能分子探针的构建及其在结直肠癌诊治中的实验研究
- 批准号:81371614
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
免疫识别因子lectin在鳞翅目寄主昆虫识别寄生蜂为“非我”过程中的作用机制研究
- 批准号:31272091
- 批准年份:2012
- 资助金额:85.0 万元
- 项目类别:面上项目
水稻花粉优势表达的L-lectin受体激酶基因OsL-LecRK7的功能研究
- 批准号:31000605
- 批准年份:2010
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
腰带长体茧蜂胚胎表面Helix pomatia lectin结合蛋白保护其逃避寄主血细胞包囊反应的机制研究
- 批准号:30971964
- 批准年份:2009
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10990669 - 财政年份:2024
- 资助金额:
$ 25.41万 - 项目类别:
Elucidating mechanisms underlying multivalency modulating lectin-glycan binding and assembly properties-implications for lectin function regulation
阐明多价调节凝集素-聚糖结合和组装特性的机制-对凝集素功能调节的影响
- 批准号:
BB/Y005856/1 - 财政年份:2024
- 资助金额:
$ 25.41万 - 项目类别:
Research Grant
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10737359 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
New Developments in Amyloidosis Research Using Cordyceps Lectin
利用冬虫夏草凝集素研究淀粉样变性的新进展
- 批准号:
23K10950 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of Blood Glycoproteins by Lectin Receptors in Health and Disease
健康和疾病中凝集素受体对血液糖蛋白的调节
- 批准号:
10658456 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
Discovery Projects
Superselective cell targeting through multivalent lectin-glycan interactions
通过多价凝集素-聚糖相互作用实现超选择性细胞靶向
- 批准号:
BB/X00158X/1 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
Research Grant
Characterization of Bacterial Lectin-Carbohydrate Binding and Development of Anti-Adhesion Inhibitors
细菌凝集素-碳水化合物结合的表征和抗粘附抑制剂的开发
- 批准号:
10625679 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
Morquio A therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat multisystemic clinical impairments of rare metabolic childhood diseases
Morquio 一种将基因转移与凝集素增强酶递送相结合的疗法,用于治疗罕见代谢性儿童疾病的多系统临床损伤
- 批准号:
10821924 - 财政年份:2023
- 资助金额:
$ 25.41万 - 项目类别:
Novel histone-binding C-type lectin receptors and their role in sterile inflammation and tissue injury
新型组蛋白结合 C 型凝集素受体及其在无菌炎症和组织损伤中的作用
- 批准号:
10566947 - 财政年份:2022
- 资助金额:
$ 25.41万 - 项目类别: